• Profile
Close

Polo-like kinase 3 is associated with poor prognosis and regulates proliferation and metastasis in prostate cancer

Cancer Management and Research Feb 22, 2019

Lin C, et al. - Researchers explored the role of polo-like kinase (Plk) 3 in prostate cancer (PCa) via Kaplan–Meier analysis and Cox regression analysis. They assessed the link between Plk3 and prognosis of patients with PCa. In gene set enrichment analysis (GSEA), they used The Cancer Genome Atlas Dataset and assessed proliferation and metastasis gene sets. The biological functions of Plk3 were determined using MTS assay, clone formation assay, cell migration, and wound healing assay. A close correlation was observed between high Plk3 expression and poor prognosis. The involvement of Plk3 in proliferation and metastasis was shown in GSEA. In vitro, Plk3 was identified as a promoter of proliferation and metastasis in PCa cells. Overall, a critical role of Plk3 in PCa was suggested.

Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay